Disclosures for "Pulmonary Safety of Staccato® Alprazolam in Healthy Participants and Participants with Mild Asthma: Phase 1, Randomized, Double-blind, Placebo-controlled Trial "
-
Dr. Miller has nothing to disclose.
-
Dr. LaForce has nothing to disclose.
-
Dr. Barlow has nothing to disclose.
-
Aliceson King has received personal compensation for serving as an employee of UCB Pharma. Aliceson King has stock in UCB.
-
Dr. Burian has received personal compensation for serving as an employee of UCB Biopharma.
-
Hugues Chanteux, 18273 has nothing to disclose.